|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/704 | |
| A61K 31/4015 | |||
| A61K 31/401 | |||
| A61P 25/08 |
| (11) | Number of the document | 2117562 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08708026.3 |
| Date of filing the European patent application | 2008-01-21 | |
| (97) | Date of publication of the European application | 2009-11-18 |
| (45) | Date of publication and mention of the grant of the patent | 2011-10-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2008/050622 |
| Date | 2008-01-21 |
| (87) | Number | WO 2008/090115 |
| Date | 2008-07-31 |
| (30) | Number | Date | Country code |
| 0701366 | 2007-01-24 | GB |
| (72) |
ALVARO, Giuseppe, IT
LARGE, Charles, IT
|
| (73) |
Glaxo Group Limited,
Glaxo Wellcome House Berkeley Avenue, Greenford, Middlesex UB6 0NN,
GB
|
| (54) | PHARMACEUTICAL COMPOSITIONS COMPRISING NK1 RECEPTOR ANTAGONISTS AND SODIUM CHANNEL BLOCKERS |
| PHARMACEUTICAL COMPOSITIONS COMPRISING NK1 RECEPTOR ANTAGONISTS AND SODIUM CHANNEL BLOCKERS |